Jane Street
RNAC icon

Jane Street’s Cartesian Therapeutics RNAC Stock Holding History

Jane Street’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,340
Closed -$124K – 10067
2024
Q1 		$124K Buy
6,340
+3,483
+122% +$73.8K ﹤0.01% 8444
2023
Q4 		$59.1K Buy
+2,857
New +$85.3K ﹤0.01% 8743
2023
Q3 		– Sell
-520
Closed -$17.5K – 9266
2023
Q2 		$17.5K Sell
520
-5,481
-91% -$196K ﹤0.01% 8372
2023
Q1 		$250K Buy
+6,001
New +$282K ﹤0.01% 7479
2022
Q4 		– Sell
-1,274
Closed -$63K – 9993
2022
Q3 		$63K Buy
1,274
+161
+14% +$8.84K ﹤0.01% 8840
2022
Q2 		$44K Buy
1,113
+738
+197% +$21.9K ﹤0.01% 8964
2022
Q1 		$14K Sell
375
-2,365
-86% -$148K ﹤0.01% 10019
2021
Q4 		$268K Buy
2,740
+2,338
+582% +$252K ﹤0.01% 8379
2021
Q3 		$50K Sell
402
-412
-51% -$49.8K ﹤0.01% 9549
2021
Q2 		$102K Buy
+814
New +$96.9K ﹤0.01% 9249
2021
Q1 		– Sell
-463
Closed -$42K – 9511
2020
Q4 		$42K Sell
463
-229
-33% -$19.9K ﹤0.01% 7335
2020
Q3 		$51K Sell
692
-4,924
-88% -$377K ﹤0.01% 6912
2020
Q2 		$478K Buy
5,616
+2,114
+60% +$192K ﹤0.01% 5153
2020
Q1 		$253K Buy
+3,502
New +$338K ﹤0.01% 4401
2019
Q3 		– Sell
-3,632
Closed -$195K – 5647
2019
Q2 		$195K Buy
+3,632
New +$248K ﹤0.01% 4700

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's RNAC Position: Q2 2024 in Review

Jane Street sold out of Cartesian Therapeutics (RNAC) in Q2 2024, closing a stake of 6,340 shares — an estimated $124K sold.

Jane Street first reported a position in RNAC in Q2 2019 and held it in 15 quarters. The position peaked at $478K in Q2 2020. 61 funds tracked by Wall St. Rank hold RNAC as of Q2 2024.

  • Jane Street reported no remaining Cartesian Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Jane Street sold 6,340 Cartesian Therapeutics shares in Q2 2024, an estimated $124K.
  • Jane Street first reported a position in Cartesian Therapeutics in Q2 2019 and held it in 15 quarters.
  • Jane Street's Cartesian Therapeutics position peaked at $478K in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.